Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $116.4600 (-1.25%) ($114.3000 - $118.7200) on Wed. Aug. 5, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.04% (three month average) | RSI | 46 | Latest Price | $116.4600(-1.25%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -1.4% a day on average for past five trading days. | Weekly Trend | LGND declines -1.5% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(54%) IWO(52%) XBI(50%) IWC(47%) IWM(47%) | Factors Impacting LGND price | LGND will decline at least -1.52% in a week (0% probabilities). VIXM(-21%) UUP(-16%) VXX(-15%) IYT(-4%) UNG(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.52% (StdDev 3.04%) | Hourly BBV | 0 () | Intraday Trend | -1.6% | | | |
|
Resistance Level | $120.27 | 5 Day Moving Average | $119.47(-2.52%) | 10 Day Moving Average | $120.91(-3.68%) | 20 Day Moving Average | $120.27(-3.17%) | To recent high | -8.1% | To recent low | 23.8% | Market Cap | $1.872b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |